Effects of the Addition of Mosapride to Gastroesophageal Reflux Disease Patients on Proton Pump Inhibitor: A Prospective Randomized, Double-blind Study

BACKGROUND/AIMS: Proton pump inhibitors (PPIs) which are the most effective agents for the treatment of gastroesophageal reflux disease (GERD), have been known to delay gastric emptying. Mosapride has been used as prokinetics by accelerating gastric emptying. We evaluated the efficacy of mosapride t...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Hyun Chul, Kim, Jie-Hyun, Youn, Young Hoon, Lee, Eun Hee, Lee, Byung Keon, Park, Hyojin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Neurogastroenterology and Motility 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816184/
https://www.ncbi.nlm.nih.gov/pubmed/24199010
http://dx.doi.org/10.5056/jnm.2013.19.4.495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816184/
https://www.ncbi.nlm.nih.gov/pubmed/24199010
http://dx.doi.org/10.5056/jnm.2013.19.4.495

Ejemplares similares